Nine intersecting genes were screened and used to construct a prognostic model, whereby seven key biomarkers—MXD3, PLCB2, CCDC88B, DEF6, IFNG, TBC1D10C, and PLEKHN1—were significantly influenced the prognosis of renal cancer. The gene discussed is PLEKHN1; the disease is renal carcinoma.